Astoria Strategic Wealth’s Heart Test Laboratories HSCS Stock Holding History

Astoria Strategic Wealth’s Portfolio HSCS Stock Details HSCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.5K	Hold	18,927	–	–	0.01%	36
2026 Q1	$47.6K	Hold	18,927	–	–	0.01%	37
2025 Q4	$58.5K	Hold	18,927	–	–	0.01%	35
2025 Q3	$65.9K	Hold	18,927	–	–	0.02%	35
2025 Q2	$71K	Hold	18,927	–	–	0.02%	35
2025 Q1	$53.4K	Buy	+18,927	New	+$63.3K	0.02%	33
2024 Q2	–	Sell	-820	Closed	-$9.59K	–	32
2024 Q1	$9.59K	Hold	820	–	–	﹤0.01%	32
2023 Q4	$14K	Hold	820	–	–	﹤0.01%	32
2023 Q3	$34.9K	Buy	820 +583	+246%	+$45.2K	0.01%	32
2023 Q2	$21.4K	Buy	+237	New	+$23.2K	0.01%	33

Other funds holding HSCS

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

FMP

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

Astoria Strategic Wealth's HSCS Position: Q2 2026 in Review

Astoria Strategic Wealth held its Heart Test Laboratories (HSCS) position steady in Q2 2026 at 18,927 shares worth $47.5K. The position accounts for 0.01% of the portfolio, ranked #36.

Astoria Strategic Wealth first reported a position in HSCS in Q2 2023 and has held it in 10 quarters since. The position peaked at $71K in Q2 2025. 3 funds tracked by Wall St. Rank hold HSCS as of Q2 2026.

Astoria Strategic Wealth held 18,927 shares of Heart Test Laboratories worth $47.5K as of Q2 2026.
Astoria Strategic Wealth left its Heart Test Laboratories share count unchanged in Q2 2026.
Heart Test Laboratories made up 0.01% of Astoria Strategic Wealth's portfolio in Q2 2026, its #36 holding.
Astoria Strategic Wealth first reported a position in Heart Test Laboratories in Q2 2023 and has held it in 10 quarters since.
Astoria Strategic Wealth's Heart Test Laboratories position peaked at $71K in Q2 2025.
3 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2026.

Based on Astoria Strategic Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.